Skip to main content

Peer Review reports

From: Effect and safety of pemafibrate for patients with type 2 diabetes mellitus and hypertriglyceridemia: a retrospective analysis of clinical data

Original Submission
2 Dec 2024 Submitted Original manuscript
7 Dec 2024 Reviewed Reviewer Report
9 Dec 2024 Reviewed Reviewer Report
13 Dec 2024 Reviewed Reviewer Report - Eiji Kutoh
24 Dec 2024 Author responded Author comments - Hirohide Yokokawa
Resubmission - Version 2
24 Dec 2024 Submitted Manuscript version 2
29 Dec 2024 Reviewed Reviewer Report - Eiji Kutoh
29 Dec 2024 Reviewed Reviewer Report
7 Jan 2025 Reviewed Reviewer Report
29 Jan 2025 Author responded Author comments - Hirohide Yokokawa
Resubmission - Version 3
29 Jan 2025 Submitted Manuscript version 3
31 Jan 2025 Author responded Author comments - Hirohide Yokokawa
Resubmission - Version 4
31 Jan 2025 Submitted Manuscript version 4
5 Feb 2025 Author responded Author comments - Hirohide Yokokawa
Resubmission - Version 5
5 Feb 2025 Submitted Manuscript version 5
Publishing
6 Feb 2025 Editorially accepted
11 Feb 2025 Article published 10.1186/s12902-025-01872-w

You can find further information about peer review here.

Back to article page